Medipurin (Mercaptopurine)

After oral absorption, mercaptopurine is converted inside cells to thioinosine monophosphate. This metabolite blocks the de novo synthesis of purine nucleotides, which are essential building blocks for DNA and RNA. The resulting shortage of nucleic acids impairs replication of rapidly dividing cells, providing both antineoplastic and immunosuppressive effects.

The dose of Medipurin is individualized by the prescribing clinician based on the specific indication, patient weight, renal and hepatic function, and other clinical factors. Dosage regimens are not standardized in public information and must be determined by a qualified healthcare professional.

Mercaptopurine is classified as Pregnancy Category D, indicating evidence of fetal risk. It should be used in pregnancy only when the potential benefit justifies the risk. Limited data are available for breastfeeding, and the drug may pass into breast milk, so a healthcare provider should be consulted before use.

To order Medipurin, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets, verifies trade or institutional credentials, and then provides pricing, availability, shipping details (including any cold‑chain requirements) and the necessary import paperwork.

The most common alternative is azathioprine, another purine analogue. Both drugs inhibit purine synthesis, but mercaptopurine is often preferred for acute lymphoblastic leukemia maintenance, while azathioprine is frequently used for broader immunosuppression. Differences in metabolism, dosing frequency, and side‑effect profiles may influence the choice of therapy.

Medipurin tablets should be stored at room temperature below 25 °C. Keep them in the original container, protect from moisture and direct light, and ensure the packaging remains tightly closed until use. Do not store in a refrigerator or freezer.

Medipurin is taken orally as a tablet, usually with a glass of water. It may be taken with or without food, but consistency with meals can help reduce gastrointestinal upset. Patients should follow the prescribing clinician’s instructions regarding timing and any necessary dose adjustments.

Serious risks include bone marrow suppression leading to anemia, neutropenia or thrombocytopenia; severe infections due to immunosuppression; hepatotoxicity with marked liver enzyme elevation; and rare events such as pancreatitis or hypersensitivity reactions. Prompt medical attention is required if symptoms such as fever, persistent fatigue, jaundice or severe abdominal pain develop.

Medipurin should be avoided in patients with known hypersensitivity to mercaptopurine or any component of the formulation. It is contraindicated in individuals with severe bone marrow failure, uncontrolled infections, or significant liver disease. Pregnant women should only use it when clearly indicated, and breastfeeding mothers should consult their physician before use.